Advertisement

Picture [iito] Männer Ballett 650x80px
Organisation › Details

Replimune Group Inc. (Nasdaq: REPL)

Replimune, headquartered in Woburn, MA, was founded in 2015 to develop the next generation of “oncolytic immunotherapies” for the treatment of cancer. Replimune is developing novel, proprietary therapeutics intended to improve the direct cancer-killing effects of selective virus replication and the potency of the immune response to the tumor antigens released. Replimune’s Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment. Replimune is rapidly advancing these therapies into clinical development in combination with other immuno-oncology products with complementary mechanisms of action. *

 

Period Start 2015-01-01 established
  Group Replimune (Group)
  Today Replimune (Group)
Products Industry BIOTECH
  Industry 2 oncolytic virus (cancer-cilling virus, virotherapy for cancer, virus-based cancer therapy)
     
  Street 18 Commerce Way
  City 01801 Woburn, MA
    Address record changed: 2018-07-21
     
Basic data Employees n. a.
     
    * Document for �About Section�: Replimune Group Inc.. (7/19/18). "Press Release: Replimune Announces Pricing of Initial Public Offering". Woburn, MA.
     
   
Record changed: 2019-07-13

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Replimune (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top